glp-1 agonists reduce inflammation Beyond Weight Loss: How Medicines Across the Body GLP-1 Agonists in Cardiovascular Diseases:

The dual agonist approach represented by tirzepatide demonstrates that activating multiple complementary pathways produces superior results to targeting a single pathway, even when that single pathway works quite well on its own

Maybe they miss drinking and dont appreciate the nausea

They increase satiety

Step 1: The Warm-up Begin with a warm-up dose of 0.25 mg once a week for the first four weeks

They treat type 2 diabetes, aid weight loss, and may improve cardiovascular health

Patients with these conditions who also have elevated inflammatory markers may experience additional anti-inflammatory benefits, but use solely for inflammation outside established indications is not recommended